Business
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results
Revenue of $259.7 million in the fourth quarter of 2020 increased 13.0% from revenue of $229.9 million for the comparable prior-year period, representing a
About this update from Medpace Holdings, Inc.
[{"type":"text","content":"\n\nRevenue of $259.7 million in the fourth quarter of 2020 increased 13.0% from revenue of $229.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.1%; Full year 2020 revenue of $925.9 million increased 7.5% from full year 2019.\n\n\nNet new business awards were $358.6 million in the fourth quarter of 2020, representing an increase of 27.6% from net new business awards of $281.1 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.38x; Full year 2020 net new business awards of $1,175.0 million increased 7.4% from the prior year.\n\n\nFourth quarter of 2020 GAAP net income was $50.9 million, or $1.35 per diluted share, versus GAAP net income of $29.8 million, or $0.78 per diluted share, for the comparable prior-year period. GAAP net income for the full year 2020 was $145.4 million, or $3.84 per diluted share, versus GAAP net income of $100.4 million, or $2.67 per diluted share, for the full year 2019. Net income margin was 19.6% for the fourth quarter of 2020 and 15.7% for the full year 2020.\n\n\nEBITDA was $60.2 million for the fourth quarter of 2020, an increase of 46.3% from EBITDA of $41.1 million for the comparable prior-year period, resulting in an EBITDA margin of 23.2%. EBITDA of $187.8 million for the full year 2020 increased 25.5% from the prior year, resulting in an EBITDA margin of 20.3%.\n\n\n CINCINNATI--(BUSINESS WIRE)--\nMedpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2020.\n\nFourth Quarter and Full Year 2020 Financial Results\n\nRevenue for the three months ended December 31, 2020 increased 13.0% to $259.7 million, compared to $229.9 million for the comparable prior-year period. Revenue for the year ended December 31, 2020 increased 7.5% to $925.9 million, compared to $861.0 million for the year ended December 31, 2019. On a constant currency organic basis, revenue for the fourth quarter of 2020 increased 12.2% compared to the fourth quarter of 2019 and increased 7.3% for the year ended December 31, 2020 compared to the year ended December 31, 2019.\n\nBacklog as of December 31, 2020 grew 20.1% to $1.5 billion from $1.3 billion as of December 31, 2019. Net new business awards were $358.6 million, representing a net book-to-bill ratio of 1....